NINTEDANIB for Covid-19: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where NINTEDANIB was used for Covid-19.
Most Reported Side Effects for NINTEDANIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 9,103 | 34.7% | 1,063 | 3,967 |
| Nausea | 4,198 | 16.0% | 349 | 1,832 |
| Dyspnoea | 3,080 | 11.7% | 500 | 1,692 |
| Decreased appetite | 2,832 | 10.8% | 348 | 1,390 |
| Death | 2,790 | 10.6% | 2,783 | 545 |
| Weight decreased | 2,628 | 10.0% | 309 | 1,278 |
| Vomiting | 2,524 | 9.6% | 238 | 1,183 |
| Fatigue | 2,511 | 9.6% | 261 | 1,094 |
| Cough | 2,193 | 8.4% | 220 | 1,016 |
| Idiopathic pulmonary fibrosis | 1,905 | 7.3% | 960 | 909 |
| Constipation | 1,756 | 6.7% | 144 | 803 |
| Abdominal pain upper | 1,664 | 6.3% | 103 | 751 |
| Asthenia | 1,487 | 5.7% | 178 | 750 |
| Headache | 1,461 | 5.6% | 66 | 577 |
| Abdominal discomfort | 1,418 | 5.4% | 76 | 635 |
Other Indications for NINTEDANIB
Idiopathic pulmonary fibrosis (13,678)
Product used for unknown indication (6,075)
Interstitial lung disease (2,999)
Pulmonary fibrosis (1,539)
Lung adenocarcinoma (793)
Non-small cell lung cancer (580)
Systemic sclerosis pulmonary (214)
Adenocarcinoma (206)
Systemic scleroderma (204)
Lung neoplasm malignant (127)
Other Drugs Used for Covid-19
REMDESIVIR (7,196)
HYDROXYCHLOROQUINE (5,280)
BAMLANIVIMAB (4,621)
NIRMATRELVIR\RITONAVIR (4,587)
TOCILIZUMAB (4,186)
DEXAMETHASONE (2,975)
CASIRIVIMAB\IMDEVIMAB (2,943)
SOTROVIMAB (2,732)
AZITHROMYCIN ANHYDROUS (2,510)
METHYLPREDNISOLONE (1,633)